Vietnam Antibacterial (Antibiotics) Drugs Market Analysis Report 2022 to 2030

Vietnam Antibacterial (Antibiotics) Drugs Market Analysis

$ 3999

Vietnam Antibacterial (Antibiotics) Drugs Market is at around $0.25 Bn in 2023 and is projected to reach $0.34 Bn in 2030, exhibiting a CAGR of 4.43% during the forecast period. The market is being driven by factors such as medical tourism, pharmaceutical industry expansion, urbanization, and changing lifestyles. The market is dominated by key players like Traphaco, Mekophar, Hau Giang Pharmaceuticals, Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, and Merck & Co., Inc.

ID: IN10VNPH005 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Aneri Parekh

Buy Now

Vietnam Antibacterial (Antibiotics) Drugs Market Executive Summary

Vietnam Antibacterial (Antibiotics) Drugs Market is at around $0.25 Bn in 2023 and is projected to reach $0.34 Bn in 2030, exhibiting a CAGR of 4.43% during the forecast period.

The manufacturing, distribution, and use of antibiotic medications within Vietnam's healthcare system are all included in the country's antibiotics market. The healthcare infrastructure, economic trends, government laws, and the incidence of infectious diseases all have an impact on this dynamic sector. To ensure good antibiotic stewardship and public health outcomes, stakeholders such as pharmaceutical companies, healthcare professionals, policymakers, and consumers must have a thorough understanding of the antibiotic usage landscape and market dynamics.

The market for antibiotics in Vietnam is steadily expanding due to increased healthcare costs and an increase in the prevalence of infectious diseases. Government programs to enhance accessibility and infrastructure for healthcare also aid in market expansion. However, obstacles to continued expansion could include new regulations and the rise of antibiotic resistance.

The antibiotic industry has changed in the last few years. In 2023, the market's value reached $50.91 Bn, and further expansion is anticipated. Infectious diseases and new product advancements are the primary causes of this surge. These developments have been facilitated by the need for additional research and development, creative antibacterial formulations, and antibiotic prescriptions. Urbanization and recent advancements in antibiotics have an impact on market expansion.

One important player in the Vietnamese antibiotic industry is Traphaco, a well-known pharmaceutical business. It is one of Vietnam's top 5 pharmaceutical businesses. Its rise was aided by the introduction of 16 new products in 2022, several of which included antibiotics. With more than 50 antibiotic solutions that address most main classes and a wide spectrum of illnesses, Traphaco is a proud supplier of antibiotics. This enables them to serve a diverse patient population with an array of prescription requirements.

Vietnam antibacterial (antibiotics) drugs market

Market Dynamics

Market Growth Drivers:

Urbanization and Changing Lifestyles: The risk of contracting infectious diseases in the country is high due to rapid urbanization and the changing lifestyle of the population hence raising the need for antibiotics.

Pharmaceutical Industry Expansion: Expansion of the Pharmaceutical Industry: The pharmaceutical industry in Vietnam, which includes the manufacture and distribution of antibiotics, stimulates market growth.

Medical Tourism: As more foreign patients travel to Vietnam for medical care, the country's growing medical tourism industry raises the demand for antibiotics. Every year, approximately 300,000 foreigners come to the nation for medical examinations and treatments.

Market Restraints:

Regulatory Restraints: Strict guidelines and rigorous approval procedures enforced by regulatory bodies may impede the introduction of novel antibiotics into the market, hence restricting prospects for expansion for pharmaceutical enterprises.

Competition from Traditional Medicine: Vietnamese traditional medicine has a strong cultural foundation, and some people may favor traditional treatments over antibiotics. This preference may limit market expansion and affect the need for antibiotics.

Economic issues: A consumer's ability to afford antibiotics can be impacted by several economic issues, including inflation, changes in currency exchange rates, and general economic stability.

Healthcare Policies and Regulatory Landscape

The Ministry of Health (MOH) and the Drug Administration of Vietnam (DAV) must authorize the importation of any medications into the country. To obtain approval from the Drug Administration of Vietnam, the manufacturer (applicant) must submit an application dossier containing all the details and supporting evidence required by the Regulation on Registration of Drugs. Clinical study conduct can be difficult in Vietnam due to a lack of appropriate facilities and trained investigators, which could delay the clearance procedure.

Competitive Landscape

Key Players:

Traphaco
Mekophar
Hau Giang Pharmaceuticals
Pfizer Inc.
AbbVie (Allergan)
Roche
Novartis AG
GlaxoSmithKline plc
Abbott Laboratories
Johnson & Johnson
Merck & Co., Inc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Antibacterial (Antibiotics) Drugs Market Segmentation

By Drug Class

Cephalosporins
Penicillin
Fluoroquinolone
Macrolides
Carbapenems
Aminoglycosides
Sulfonamides
7-ACA
Others

By Type

Branded Antibiotics
Generic Antibiotics

By Action Mechanism

Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Mycolic Acid Inhibitors
Others

By Spectrum

Broad-spectrum Antibiotic
Narrow-spectrum Antibiotic

By Administration

Oral
Intravenous
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.